Fig. 4From: Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemiaPhase 1b/2 trial of ibrutinib monotherapy in elderly patients with CLL/SLL [61]. a Progression-free survival. b Overall survival. + = censored. CLL chronic lymphocytic leukemia, SLL small lymphocytic lymphoma. Reproduced with permission from [61]Back to article page